Back to Search

CDTX

Cidara Therapeutics, Inc.
Data: 2026-01-06
$221.38
Price
0.03%
Change
$221.42
52W High
$15.22
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats

49.9

AI Score

HOLD

3.36

Volume Ratio

TBA

Next Earnings

22

+ve Days (30d)

8

-ve Days (30d)

CDTX Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

CDTX Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

CDTX Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CDTX Daily Out of Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CDTX Daily In the Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CDTX Most Active Options by Volume(near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
CDTX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CDTX Stock Summary

Last updated

CDTX is currently trading at $221.38, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $15.22 to $221.42.

Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CDTX at 49.9/100 with a HOLD recommendation.

CDTX Candlestick Patterns

No validated candlestick patterns fired for CDTX in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

Cidara Therapeutics, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.

CDTX Moving Averages Analysis

CDTX (Cidara Therapeutics, Inc.) Simple Moving Averages

Moving Averages are last updated

Days MA

CDTX Fundamental Analysis

P/E (Forward) 5.7504
P/E (Trailing) --
Market Cap ($) 7.0 billion
Earnings/Share ($) -11.22
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -8.0704
EPS Estimate Next Year ($) -6.2903
WallStreet Target Price ($) 221.50
Most Recent Quarter

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.